Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Culture of human alveolar epithelial type II cells by sprouting.

Khan P, Fytianos K, Tamò L, Roth M, Tamm M, Geiser T, Gazdhar A, Hostettler KE.

Respir Res. 2018 Oct 19;19(1):204. doi: 10.1186/s12931-018-0906-9.

2.

Generation of an alveolar epithelial type II cell line from induced pluripotent stem cells.

Tamò L, Hibaoui Y, Kallol S, Alves MP, Albrecht C, Hostettler KE, Feki A, Rougier JS, Abriel H, Knudsen L, Gazdhar A, Geiser T.

Am J Physiol Lung Cell Mol Physiol. 2018 Dec 1;315(6):L921-L932. doi: 10.1152/ajplung.00357.2017. Epub 2018 Sep 13.

PMID:
30211653
3.

Multipotent mesenchymal stem cells in lung fibrosis.

Hostettler KE, Gazdhar A, Khan P, Savic S, Tamo L, Lardinois D, Roth M, Tamm M, Geiser T.

PLoS One. 2017 Aug 21;12(8):e0181946. doi: 10.1371/journal.pone.0181946. eCollection 2017. Erratum in: PLoS One. 2018 Jan 9;13(1):e0191144.

4.

Constitutive high expression of protein arginine methyltransferase 1 in asthmatic airway smooth muscle cells is caused by reduced microRNA-19a expression and leads to enhanced remodeling.

Sun Q, Liu L, Wang H, Mandal J, Khan P, Hostettler KE, Stolz D, Tamm M, Molino A, Lardinois D, Lu S, Roth M.

J Allergy Clin Immunol. 2017 Aug;140(2):510-524.e3. doi: 10.1016/j.jaci.2016.11.013. Epub 2017 Jan 9.

PMID:
28081849
5.

Osteolysis of unknown origin: a case report.

Wiesli MG, Hostettler KE, Tamm M, Jaquiéry C.

BMC Oral Health. 2015 Dec 30;15:168. doi: 10.1186/s12903-015-0158-8.

6.

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.

Wollin L, Wex E, Pautsch A, Schnapp G, Hostettler KE, Stowasser S, Kolb M.

Eur Respir J. 2015 May;45(5):1434-45. doi: 10.1183/09031936.00174914. Epub 2015 Mar 5. Review.

7.

Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.

Hostettler KE, Zhong J, Papakonstantinou E, Karakiulakis G, Tamm M, Seidel P, Sun Q, Mandal J, Lardinois D, Lambers C, Roth M.

Respir Res. 2014 Dec 12;15:157. doi: 10.1186/s12931-014-0157-3.

8.

Whole-body magnetic resonance imaging in extrathoracic sarcoidosis.

Hostettler KE, Bratu VA, Fischmann A, Tamm M, Studler U.

Eur Respir J. 2014 Jun;43(6):1812-5. doi: 10.1183/09031936.00008914. Epub 2014 Mar 13. No abstract available.

9.

Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.

Hostettler KE, Halter JP, Gerull S, Lardinois D, Savic S, Roth M, Tamm M.

Eur Respir J. 2014 Jan;43(1):221-32. doi: 10.1183/09031936.00199312. Epub 2013 May 3.

10.

Dimethylfumarate inhibits CXCL10 via haem oxygenase-1 in airway smooth muscle.

Seidel P, Hostettler KE, Hughes JM, Tamm M, Roth M.

Eur Respir J. 2013 Jan;41(1):195-202. doi: 10.1183/09031936.00068411. Epub 2012 Jul 12.

11.

Long-term treatment with infliximab in patients with sarcoidosis.

Hostettler KE, Studler U, Tamm M, Brutsche MH.

Respiration. 2012;83(3):218-24. doi: 10.1159/000328738. Epub 2011 Jul 29.

12.

Airway epithelium-derived transforming growth factor-beta is a regulator of fibroblast proliferation in both fibrotic and normal subjects.

Hostettler KE, Roth M, Burgess JK, Gencay MM, Gambazzi F, Black JL, Tamm M, Borger P.

Clin Exp Allergy. 2008 Aug;38(8):1309-17. doi: 10.1111/j.1365-2222.2008.03017.x. Epub 2008 May 22.

PMID:
18503568
13.

Cyclosporine A mediates fibroproliferation through epithelial cells.

Hostettler KE, Roth M, Burgess JK, Johnson PR, Glanville AR, Tamm M, Black JL, Borger P.

Transplantation. 2004 Jun 27;77(12):1886-93.

PMID:
15223908

Supplemental Content

Loading ...
Support Center